Skip to content

Assessment of Primary Tumor Surgery on Survival in Patients with Bone Metastases: A Retrospective Cohort Study Using SEER Data

Assessment of Primary Tumor Surgery on Survival in Patients with Bone Metastases Using Propensity Score Matching: A Retrospective Cohort Study with SEER Data - PTS-SBM: Primary Tumor Surgery in Survival Outcomes of Patients with Bone Metastases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090161
Enrollment
Unknown
Registered
2024-09-25
Start date
2023-06-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pan-cancer

Interventions

Patients with Bone Metastases across Various Cancer Types.:None

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (i) patients with BM originating from primary cancers of the lung, prostate, breast, kidney, bladder, or liver; (ii) individuals whose primary cancer was their first and only diagnosis; (iii) patients aged 18 years or older at the time of their primary cancer diagnosis; (iv) patients diagnosed with BM between 2010 and 2019; (v) patients with BM at diagnosis without any metastases to the liver, lungs, or brain.

Exclusion criteria

Exclusion criteria: (i) diagnosis not confirmed microscopically; (ii) cancer diagnosed only at autopsy or on a death certificate; (iii) diagnosis with T0, indicating that no primary tumor was identified, or with non-invasive tumor stages Ta and Tis owing to small sample sizes; (iv) unknown status of PTS; (v) unknown status of metastasectomy (MS); (vi) incomplete follow-up data

Design outcomes

Primary

MeasureTime frame
Overall survival (OS);Cancer-specific Survival (CSS);

Countries

China

Contacts

Public ContactWangjun Yan

Fudan University Shanghai Cancer Center

yanwj@fudan.edu.cn+86 139 1796 6770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026